 | • レポートコード：MRC23Q35991 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の顔面リポジストロフィー治療剤市場について調査・分析し、世界の顔面リポジストロフィー治療剤市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（皮膚フィラー、手術）、用途別セグメント分析（病院、専門クリニック、美容整形センター）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Galderma Laboratories、Merz GmbH & Co. KGaA、Sanofi SA、Zimmer Biomet、Anika Therapeutics、Ferring BV、Bioventusなどが含まれています。世界の顔面リポジストロフィー治療剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、顔面リポジストロフィー治療剤市場規模を推定する際に考慮しました。本レポートは、顔面リポジストロフィー治療剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、顔面リポジストロフィー治療剤に関するビジネス上の意思決定に役立てることを目的としています。 ・顔面リポジストロフィー治療剤市場の概要 - 顔面リポジストロフィー治療剤のタイプ別セグメント - 世界の顔面リポジストロフィー治療剤市場規模：タイプ別分析（皮膚フィラー、手術） - 顔面リポジストロフィー治療剤の用途別セグメント - 世界の顔面リポジストロフィー治療剤市場規模：用途別分析（病院、専門クリニック、美容整形センター） - 世界の顔面リポジストロフィー治療剤市場規模予測（2018年-2029年） ・顔面リポジストロフィー治療剤市場の成長トレンド - 顔面リポジストロフィー治療剤の地域別市場規模（2018年-2029年） - 顔面リポジストロフィー治療剤市場ダイナミクス - 顔面リポジストロフィー治療剤の業界動向 - 顔面リポジストロフィー治療剤市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：皮膚フィラー、手術 - 世界の顔面リポジストロフィー治療剤のタイプ別市場規模（2018年-2023年） - 世界の顔面リポジストロフィー治療剤のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、専門クリニック、美容整形センター - 世界の顔面リポジストロフィー治療剤の用途別市場規模（2018年-2023年） - 世界の顔面リポジストロフィー治療剤の用途別市場規模（2024年-2029年） ・顔面リポジストロフィー治療剤の地域別市場規模 - 北米の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - アメリカの顔面リポジストロフィー治療剤市場規模（2018年-2029年） - ヨーロッパの顔面リポジストロフィー治療剤市場規模（2018年-2029年） - アジア太平洋の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - 中国の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - 日本の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - 韓国の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - インドの顔面リポジストロフィー治療剤市場規模（2018年-2029年） - オーストラリアの顔面リポジストロフィー治療剤市場規模（2018年-2029年） - 中南米の顔面リポジストロフィー治療剤市場規模（2018年-2029年） - 中東・アフリカの顔面リポジストロフィー治療剤市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Galderma Laboratories、Merz GmbH & Co. KGaA、Sanofi SA、Zimmer Biomet、Anika Therapeutics、Ferring BV、Bioventus ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Facial Lipodystrophy Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Facial Lipodystrophy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Facial Lipodystrophy Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Facial Lipodystrophy Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Facial Lipodystrophy Treatment include Galderma Laboratories, Merz GmbH & Co. KGaA, Sanofi SA, Zimmer Biomet, Anika Therapeutics, Ferring BV and Bioventus, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Facial Lipodystrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Lipodystrophy Treatment.
The Facial Lipodystrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Facial Lipodystrophy Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Facial Lipodystrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Galderma Laboratories
Merz GmbH & Co. KGaA
Sanofi SA
Zimmer Biomet
Anika Therapeutics
Ferring BV
Bioventus
Segment by Type
Dermal Filler
Surgery
Segment by Application
Hospital
Specialty Clinics
Plastic Surgery Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Facial Lipodystrophy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Facial Lipodystrophy Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Dermal Filler
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Facial Lipodystrophy Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Plastic Surgery Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Facial Lipodystrophy Treatment Market Perspective (2018-2029)
2.2 Facial Lipodystrophy Treatment Growth Trends by Region
2.2.1 Global Facial Lipodystrophy Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Facial Lipodystrophy Treatment Historic Market Size by Region (2018-2023)
2.2.3 Facial Lipodystrophy Treatment Forecasted Market Size by Region (2024-2029)
2.3 Facial Lipodystrophy Treatment Market Dynamics
2.3.1 Facial Lipodystrophy Treatment Industry Trends
2.3.2 Facial Lipodystrophy Treatment Market Drivers
2.3.3 Facial Lipodystrophy Treatment Market Challenges
2.3.4 Facial Lipodystrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Facial Lipodystrophy Treatment Players by Revenue
3.1.1 Global Top Facial Lipodystrophy Treatment Players by Revenue (2018-2023)
3.1.2 Global Facial Lipodystrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Facial Lipodystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Facial Lipodystrophy Treatment Revenue
3.4 Global Facial Lipodystrophy Treatment Market Concentration Ratio
3.4.1 Global Facial Lipodystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Facial Lipodystrophy Treatment Revenue in 2022
3.5 Facial Lipodystrophy Treatment Key Players Head office and Area Served
3.6 Key Players Facial Lipodystrophy Treatment Product Solution and Service
3.7 Date of Enter into Facial Lipodystrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Facial Lipodystrophy Treatment Breakdown Data by Type
4.1 Global Facial Lipodystrophy Treatment Historic Market Size by Type (2018-2023)
4.2 Global Facial Lipodystrophy Treatment Forecasted Market Size by Type (2024-2029)
5 Facial Lipodystrophy Treatment Breakdown Data by Application
5.1 Global Facial Lipodystrophy Treatment Historic Market Size by Application (2018-2023)
5.2 Global Facial Lipodystrophy Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Facial Lipodystrophy Treatment Market Size (2018-2029)
6.2 North America Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
6.4 North America Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Facial Lipodystrophy Treatment Market Size (2018-2029)
7.2 Europe Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
7.4 Europe Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Facial Lipodystrophy Treatment Market Size (2018-2029)
8.2 Asia-Pacific Facial Lipodystrophy Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Facial Lipodystrophy Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Facial Lipodystrophy Treatment Market Size (2018-2029)
9.2 Latin America Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
9.4 Latin America Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Facial Lipodystrophy Treatment Market Size (2018-2029)
10.2 Middle East & Africa Facial Lipodystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Facial Lipodystrophy Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galderma Laboratories
11.1.1 Galderma Laboratories Company Detail
11.1.2 Galderma Laboratories Business Overview
11.1.3 Galderma Laboratories Facial Lipodystrophy Treatment Introduction
11.1.4 Galderma Laboratories Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.1.5 Galderma Laboratories Recent Development
11.2 Merz GmbH & Co. KGaA
11.2.1 Merz GmbH & Co. KGaA Company Detail
11.2.2 Merz GmbH & Co. KGaA Business Overview
11.2.3 Merz GmbH & Co. KGaA Facial Lipodystrophy Treatment Introduction
11.2.4 Merz GmbH & Co. KGaA Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.2.5 Merz GmbH & Co. KGaA Recent Development
11.3 Sanofi SA
11.3.1 Sanofi SA Company Detail
11.3.2 Sanofi SA Business Overview
11.3.3 Sanofi SA Facial Lipodystrophy Treatment Introduction
11.3.4 Sanofi SA Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.3.5 Sanofi SA Recent Development
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Detail
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Facial Lipodystrophy Treatment Introduction
11.4.4 Zimmer Biomet Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.4.5 Zimmer Biomet Recent Development
11.5 Anika Therapeutics
11.5.1 Anika Therapeutics Company Detail
11.5.2 Anika Therapeutics Business Overview
11.5.3 Anika Therapeutics Facial Lipodystrophy Treatment Introduction
11.5.4 Anika Therapeutics Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.5.5 Anika Therapeutics Recent Development
11.6 Ferring BV
11.6.1 Ferring BV Company Detail
11.6.2 Ferring BV Business Overview
11.6.3 Ferring BV Facial Lipodystrophy Treatment Introduction
11.6.4 Ferring BV Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.6.5 Ferring BV Recent Development
11.7 Bioventus
11.7.1 Bioventus Company Detail
11.7.2 Bioventus Business Overview
11.7.3 Bioventus Facial Lipodystrophy Treatment Introduction
11.7.4 Bioventus Revenue in Facial Lipodystrophy Treatment Business (2018-2023)
11.7.5 Bioventus Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details